Regional Anesthesia and Lung Cancer Recurrence
Test the effect of combined regiona/general anesthesia on lung cancer recurrence compared to general anesthesia alone.
Checked against the public recordLast updated Sep 15, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- The Cleveland Clinic
- Interventions being studied
- Other: General-epidural anesthesia; Other: Balanced general anesthesia and postoperative opioids
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Primary non-small cell lung cancer (stage 1-3) as determined according to the IASLC Lung Cancer Staging Project; * Scheduled for potentially curative tumor resection; * Written informed consent, including willingness to be randomized to epidural anesthesia/analgesia plus general anesthesia or to general anesthesia and postoperative opioid analgesia. Exclusion Criteria: * Any contraindication to epidural anesthesia, (including coagulopathy, abnormal anatomy). * Any contraindication to midazolam, propofol, sevoflurane, fentanyl, morphine, or hydromorphone. * Age \< 18 or \> 85 years old. * Other cancer not believed by the attending surgeon to be in long-term remission.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Cleveland ClinicCleveland, Ohio
- Shanghai Chest HospitalShanghai
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 15, 2016. Always confirm current availability with the study team.